GlassScriptPhysician profile
Iftequar U Ahmed
NPI 1174591119
$398.43
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $75.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $76.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.55 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $66.55 | 2019-2020 | |
| Glaxosmithkline, LLC. | $38.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.07 | 2019-2020 | |
| Lilly USA, LLC | $25.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.22 | 2020 | |
| Novo Nordisk INC | $20.64 | 2019 | |
| Pfizer INC. | $13.98 | 2019 | |
| Allergan, INC. | $11.75 | 2020 | |
| Amarin Pharma, INC. | $11.25 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iftequar Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.